Details of the Drug

General Information of Drug (ID: DMZ6TF1)

Drug Name

ProTmune

Indication

Disease Entry	ICD 11	Status	REF
Refractory hematologic malignancy	2A85.5	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02743351) Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies. U.S. National Institutes of Health.